ATE202934T1 - Topisch verabreichbare zinkphthalocyaninhaltige mittel - Google Patents

Topisch verabreichbare zinkphthalocyaninhaltige mittel

Info

Publication number
ATE202934T1
ATE202934T1 AT95309102T AT95309102T ATE202934T1 AT E202934 T1 ATE202934 T1 AT E202934T1 AT 95309102 T AT95309102 T AT 95309102T AT 95309102 T AT95309102 T AT 95309102T AT E202934 T1 ATE202934 T1 AT E202934T1
Authority
AT
Austria
Prior art keywords
phthalocyan
containing zinc
agents containing
topically administerable
topically
Prior art date
Application number
AT95309102T
Other languages
English (en)
Inventor
William G Love
Original Assignee
Novartis Erfind Verwalt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Erfind Verwalt Gmbh filed Critical Novartis Erfind Verwalt Gmbh
Application granted granted Critical
Publication of ATE202934T1 publication Critical patent/ATE202934T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
AT95309102T 1995-01-05 1995-12-14 Topisch verabreichbare zinkphthalocyaninhaltige mittel ATE202934T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9500116.0A GB9500116D0 (en) 1995-01-05 1995-01-05 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE202934T1 true ATE202934T1 (de) 2001-07-15

Family

ID=10767610

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95309102T ATE202934T1 (de) 1995-01-05 1995-12-14 Topisch verabreichbare zinkphthalocyaninhaltige mittel

Country Status (12)

Country Link
US (1) US5723148A (de)
EP (1) EP0720853B1 (de)
JP (1) JPH08231428A (de)
KR (1) KR960028918A (de)
AT (1) ATE202934T1 (de)
AU (1) AU4068395A (de)
CA (1) CA2166527A1 (de)
DE (1) DE69521672D1 (de)
GB (1) GB9500116D0 (de)
IL (1) IL116599A0 (de)
NZ (1) NZ280743A (de)
ZA (1) ZA9641B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001511128A (ja) * 1997-01-28 2001-08-07 ファルマシア・アンド・アップジョン・カンパニー 水不溶性ポルフィリンの脂質錯体の凍結乾燥物
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
EP0911023A1 (de) * 1998-03-20 1999-04-28 Mario Luca Russo Photosensibilisierende Stoffe enthaltende pharmazeutische oder kosmetische Zubereitung
US8093293B2 (en) * 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8106094B2 (en) * 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US20020197244A1 (en) * 1998-12-07 2002-12-26 Miri Seiberg Compositions and methods for regulating phagocytosis and ICAM-1 expression
CA2356959C (en) * 1998-12-22 2009-03-31 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Water-insoluble drug delivery system
US6682758B1 (en) 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
US6608050B2 (en) 1999-07-20 2003-08-19 Pharmacia & Upjohn Company Lyophilizate of lipid complex of water insoluble porphyrins
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7309688B2 (en) * 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US8431550B2 (en) * 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
US7192615B2 (en) * 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
DE60237162D1 (de) * 2001-10-03 2010-09-09 Celator Pharmaceuticals Inc Liposomenladung mit metallionen
US20030224075A1 (en) * 2002-02-21 2003-12-04 Jue-Chen Liu Soy composition for balancing combination skin
US20040063593A1 (en) * 2002-09-30 2004-04-01 Wu Jeffrey M. Compositions containing a cosmetically active organic acid and a legume product
US20050004561A1 (en) * 2003-07-01 2005-01-06 Lynn Halas Method for removing hair
WO2005048969A1 (en) * 2003-10-29 2005-06-02 Johnson & Johnson Consumer France S.A.S. Compositions comprising soy products and dioic acids
WO2005099689A1 (en) * 2004-04-01 2005-10-27 Case Western Reserve University Topical delivery of phthalocyanines
EP1909758A1 (de) * 2005-08-02 2008-04-16 I.D.M. Immuno-Designed Molecules Verfahren zur herstelung von liposomalen formulierungen
US20080008818A1 (en) * 2006-06-23 2008-01-10 Miri Seiberg Partially denatured whole soybean extracts and methods of use thereof
US20080089960A1 (en) * 2006-10-16 2008-04-17 Miri Seiberg Use of Legume Products for the Treatment and Prevention of Radiotherapy-Induced Skin Damage
CZ2006743A3 (cs) * 2006-11-28 2008-03-26 Fyziologický ústav AV CR Liposomální gelový ftalocyaninový prípravek pro fotodynamickou terapii nádorových onemocnení a zpusob jeho prípravy
US20100196455A1 (en) * 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US8440641B2 (en) 2009-03-20 2013-05-14 Case Western Reserve University Phthalocyanine salt formulations
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
KR20210108505A (ko) * 2013-07-03 2021-09-02 광동 클록스 바이오메디컬 그룹 씨오., 엘티디 상처를 치료하기 위한 발색단과 겔화제를 포함하는 생체광자성 조성물
RU2016142722A (ru) 2014-04-01 2018-05-04 Клокс Текнолоджиз Инк. Композиции наполнителей для тканей и способы их применения
CN105363031B (zh) * 2014-09-01 2019-04-02 北京贵千金医药科技有限公司 α-(8-喹啉氧基)单取代酞菁锌治疗银屑病的用途
WO2016065488A1 (en) 2014-10-31 2016-05-06 Klox Technologies Inc. Photoactivatable fibers and fabric media
US10723694B2 (en) * 2018-10-02 2020-07-28 Kuwait University Propargyl-functionalized macrocyclic compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
US5064655A (en) * 1989-02-24 1991-11-12 Liposome Technology, Inc. Liposome gel composition and method
US4973468A (en) * 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
US5270053A (en) 1990-04-03 1993-12-14 Ciba-Geigy Corp. Parenterally administerable liposome formulation comprising synthetic lipid
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
JPH0753381A (ja) * 1993-07-09 1995-02-28 Ciba Geigy Ag 局所投与可能な亜鉛フタロシアニン組成物
GB9317881D0 (en) * 1993-08-27 1993-10-13 Secr Defence Photosensitizers

Also Published As

Publication number Publication date
NZ280743A (en) 1997-03-24
US5723148A (en) 1998-03-03
EP0720853B1 (de) 2001-07-11
CA2166527A1 (en) 1996-07-06
GB9500116D0 (en) 1995-03-01
AU4068395A (en) 1996-07-11
IL116599A0 (en) 1996-03-31
DE69521672D1 (de) 2001-08-16
ZA9641B (en) 1996-08-16
JPH08231428A (ja) 1996-09-10
EP0720853A1 (de) 1996-07-10
KR960028918A (ko) 1996-08-17

Similar Documents

Publication Publication Date Title
ATE202934T1 (de) Topisch verabreichbare zinkphthalocyaninhaltige mittel
DE59310399D1 (de) Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
NO307205B1 (no) Preparater basert på virkestoffer fra taxanklassen samt perfusjonspreparater inneholdende disse
AU6985691A (en) Pharmaceutical and cosmetic compositions
MX9602955A (es) Procedimiento para solubizar activos farmaceuticos dificilmente solubles.
ES2166799T3 (es) Formulaciones farmaceuticas que contienen raloxifeno, un tensioactivo y un diluyente soluble en agua.
DE69328681T2 (de) Selbstschmierende polybenzimidazole enthaltende zusammensetzung
PT84690B (pt) Processo de preparacao de novos derivados da benzodiazepina e de composicoes farmaceuticas que os contem
PT99503A (pt) Processo para a preparacao de novos derivados da n-benzoil-prolina e de composicoes farmaceuticas que os contem
ES2111871T3 (es) Nuevos derivados de aminoacidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ATE160931T1 (de) Lichtstabile farbzusammensetzungen
ES2160308T3 (es) Nuevos derivados amino-metil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DK99987A (da) Oestrogenpraeparater
EP0470431A3 (en) Use of phosphomycin and the pharmaceutically acceptable salts thereof as a topical cicatrizer
MY114213A (en) Clavulanic acid salts
NO923266D0 (no) Heksahydrobenzo(f)quinolinoner
DK0579939T3 (da) Phospholipidderivater
DK0804927T3 (da) Multiantioxidantholdigt medikament
ATE118763T1 (de) Phenolisches amin als antimelanoma- und depigmentierungsmittel.
DE59404879D1 (de) Farbbildnergemisch
SE8304111L (sv) Aminoderivat av bensyliden-pyrrolo(2,1-b)kinazoliner och bensyliden-pyrido(2,1-b)kinazoliner
NO994787L (no) Forbedringer i eller vedrörende langtidsvirkende antimikrobielle midler

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties